- Clinical Features and Treatment Outcomes of Immune Thrombocytopenic Purpura in Infants: A Single Center Retrospective Study
-
Sohn SJ, Park KM, Yang EJ, Lim YT
- KMID: 2464253
- Clin Pediatr Hematol Oncol.
- 2019 Oct;26(2):77-82.
- doi: 10.15264/cpho.2019.26.2.77
BACKGROUND: Immune thrombocytopenic purpura (ITP) in children less than one year of age is less well characterized compared to ITP in toddlers and school-age children. Since children of different ages... -
- CITED
-
- Close
- SHARE
-
- Close
- A case of immune thrombocytopenia associated with invasive thymoma successfully treated with eltrombopag
-
Yoon JK, Jang HR, Park JH, Kim KH, Roh EY, Byun JM
- KMID: 2451059
- Blood Res.
- 2019 Mar;54(1):74-79.
- doi: 10.5045/br.2019.54.1.74
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
-
Kim CH, Choi YS, Moon JY, Kim DY, Lee SY, Lee HJ, Yun HJ, Kim S, Jo DY, Song IC
- KMID: 2441018
- Korean J Intern Med.
- 2019 Mar;34(2):383-389.
- doi: 10.3904/kjim.2015.070
BACKGROUND/AIMS: Few studies have addressed whether there are differences in clinical efficacy between intravenous methylprednisolone (methyl-Pd) and intravenous immunoglobulin (IVIg) use. METHODS: We retrospectively compared platelet responses and toxicities associated with... -
- CITED
-
- Close
- SHARE
-
- Close
- The Efficacy of High Dose Dexamethasone Therapy in Children with Immune Thrombocytopenic Purpura
-
Lee HO, Chang SH, Baek HJ, Kim HS, Park SM, Shin MG, Kook H
- KMID: 2435401
- Clin Pediatr Hematol Oncol.
- 2018 Oct;25(2):102-107.
- doi: 10.15264/cpho.2018.25.2.102
BACKGROUND: Few studies of high dose dexamethasone (HD-DXM) therapy in children with immune thrombocytopenic purpura (ITP) have been reported. The purpose of this study is to investigate efficacy and safety... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Courses and Outcome of Newly Diagnosed Immune Thrombocytopenia in Infants
-
Hwang NR, Park KD
- KMID: 2435400
- Clin Pediatr Hematol Oncol.
- 2018 Oct;25(2):97-101.
- doi: 10.15264/cpho.2018.25.2.97
BACKGROUND: Infants with immune thrombocytopenia (ITP) are at increased risk of high risk bleeding and vaccination-associated ITP. Infants with ITP respond favorably to treatment and are less likely to develop... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP)
-
Hong J, Bang SM, Mun YC, Yhim HY, Lee J, Lim HS, Oh D, on behalf of the Korean GC IVIg Investigators
- KMID: 2410527
- J Korean Med Sci.
- 2018 May;33(19):e142.
- doi: 10.3346/jkms.2018.33.e142
BACKGROUND: In the current study, we aimed to investigate the efficacy and safety of intravenous immunoglobulin (IVIg)-SN 10%, a new 10% IVIg formulation, in adult patients with severe primary immune... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Approach of Childhood Immune Thrombocytopenia
-
Kim JY
- KMID: 2435418
- Clin Pediatr Hematol Oncol.
- 2018 Apr;25(1):10-16.
- doi: 10.15264/cpho.2018.25.1.10
Immune thrombocytopenia (ITP) is the most common cause of thrombocytopenia in children and can be defined as an autoimmune disorder of isolated thrombocytopenia without other causes of thrombocytopenia. This review... -
- CITED
-
- Close
- SHARE
-
- Close
- New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
-
Yoon JS, Lee YJ, Baek DW, Park HY, Park BE, Moon JH, Sohn SK
- KMID: 2411556
- Korean J Intern Med.
- 2018 Mar;33(2):435-437.
- doi: 10.3904/kjim.2015.252
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Life-threating outcomes after dental implantation in patient with idiopathic thrombocytopenic purpura: a case report and review of literature
-
Lee ST, Kim JW, Kwon TG
- KMID: 2431962
- Maxillofac Plast Reconstr Surg.
- 2018 ;40(1):39.
- doi: 10.1186/s40902-018-0178-9
BACKGROUND: Patients with chronic ITP (idiopathic thrombocytopenia) frequently do not require comprehensive medication for daily life. Usually, it had been regarded that postoperative bleeding after a simple or surgical extraction... -
- CITED
-
- Close
- SHARE
-
- Close
- Interleukin-1B (IL-1B-31 and IL-1B-511) and interleukin-1 receptor antagonist (IL-1Ra) gene polymorphisms in primary immune thrombocytopenia
-
Yadav DK, Tripathi A, Gupta D, Shukla S, Singh AK, Kumar A, Agarwal J, Prasad KN
- KMID: 2405062
- Blood Res.
- 2017 Dec;52(4):264-269.
- doi: 10.5045/br.2017.52.4.264
BACKGROUND: Immune thrombocytopenia (ITP) is an immune-mediated disease caused by autoantibodies against platelets membrane glycoproteins GPIIb/IIIa and GPIb/IX. The etiology of ITP remains unclear. This study evaluated the association of... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of immune thrombocytopenia: Korean experts recommendation in 2017
-
Jang JH, Kim JY, Mun YC, Bang SM, Lim YJ, Shin DY, Choi YB, Yhim HY, Lee JW, Kook H, on the behalf of Korean Aplastic Anemia Working Party
- KMID: 2405061
- Blood Res.
- 2017 Dec;52(4):254-263.
- doi: 10.5045/br.2017.52.4.254
Management options for patients with immune thrombocytopenia (ITP) have evolved substantially over the past decades. The American Society of Hematology published a treatment guideline for clinicians referring to the management... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Course of Childhood Immune Thrombocytopenic Purpura and Analysis Predicting Factor of Prognosis
-
Lee T, Choi J, Lim YJ
- KMID: 2396008
- Clin Pediatr Hematol Oncol.
- 2017 Oct;24(2):88-92.
- doi: 10.15264/cpho.2017.24.2.88
BACKGROUND: Immune thrombocytopenic purpura (ITP) is an acquired bleeding disorder in which the immune system destroys platelets. There were many studies which predicted the factors associated with the prognosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- Dapsone therapy for refractory immune thrombocytopenia patients: a case series
-
Lee JY, Lee JO, Jung JY, Bang SM
- KMID: 2413325
- Blood Res.
- 2017 Jun;52(2):95-99.
- doi: 10.5045/br.2017.52.2.95
BACKGROUND: Dapsone has been recommended as a second-line immunosuppressive agent for patients with immune thrombocytopenia (ITP). METHODS: We retrospectively analyzed the efficacy and safety of dapsone therapy in patients with ITP. RESULTS:... -
- CITED
-
- Close
- SHARE
-
- Close
- Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar
-
Song J
- KMID: 2413320
- Blood Res.
- 2017 Jun;52(2):77-78.
- doi: 10.5045/br.2017.52.2.77
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Aseptic Meningitis and Acute Kidney Injury after Immunoglobulin Infusion in a Patient with Systemic Lupus Erythematosus and Immune Thrombocytopenic Purpura
-
Jo S, Oh EH, Lee JY, Cho YK, Kwon OC, Ghang B, Kim YG
- KMID: 2378091
- J Rheum Dis.
- 2017 Apr;24(2):119-122.
- doi: 10.4078/jrd.2017.24.2.119
A 36-yr-old woman with systemic lupus erythematosus was admitted in our center because of thrombocytopenia that was being treated with corticosteroids. She was prescribed a four-day course of intravenous immunoglobulin... -
- CITED
-
- Close
- SHARE
-
- Close
- Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
-
Jung CW, Cho SH, Park S, Jang JH, Ji JH
- KMID: 2364326
- Blood Res.
- 2016 Dec;51(4):297-299.
- doi: 10.5045/br.2016.51.4.297
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia
-
Cura M, Koç A, Aksoy N, Özdemir Z
- KMID: 2364317
- Blood Res.
- 2016 Dec;51(4):261-267.
- doi: 10.5045/br.2016.51.4.261
BACKGROUND: Immune thrombocytopenia (ITP) is the most common cause of acquired childhood thrombocytopenia and is characterized by increased immune-mediated destruction of circulating thrombocytes. Oxidative damage may be involved in ITP... -
- CITED
-
- Close
- SHARE
-
- Close
- Neutrophil to Lymphocyte Ratio (NLR) as a Predictive Marker for Prognosis in the Patients with Immune Thrombocytopenic Purpura (ITP)
-
Yang GE, Lee MJ, Yoo JH, Chueh HW
- KMID: 2358363
- Clin Pediatr Hematol Oncol.
- 2016 Oct;23(2):83-89.
- doi: 10.15264/cpho.2016.23.2.83
BACKGROUND: Immune thrombocytopenic purpura (ITP) is an autoimmune disorder presenting low platelet count in peripheral blood without any other abnormalities in other blood cell lineage. There were many studies that... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years
-
Jung JY, O AR, Kim JK, Park M
- KMID: 2350498
- Korean J Pediatr.
- 2016 Aug;59(8):335-340.
- doi: 10.3345/kjp.2016.59.8.335
PURPOSE: This study aimed to evaluate the clinical course of childhood immune thrombocytopenia (ITP) and to assess the risk factors for developing chronic ITP. METHODS: The records of 64 children diagnosed... -
- CITED
-
- Close
- SHARE
-
- Close
- Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia
-
Choi HS, Ji MH, Kim SJ, Ahn HS
- KMID: 2309210
- Blood Res.
- 2016 Jun;51(2):95-101.
- doi: 10.5045/br.2016.51.2.95
BACKGROUND: Childhood immune thrombocytopenic purpura (ITP) is a common acquired bleeding disorder. Even though most children recover, either spontaneously or with therapy, 10-20% of newly diagnosed ITP cases have a... -
- CITED
-
- Close
- SHARE
-
- Close
